NO2020018I1
(no )
2020-06-17
Darolutamide, optionally in the form of a pharmaceutically acceptable salt or ester thereof
NO2020006I1
(no )
2020-03-11
upadacitinib or a pharmaceutically acceptable salt thereof
NO2022033I1
(no )
2022-07-22
Rimegepant or a pharmaceutically acceptable salt thereof
CY2019025I1
(el )
2019-11-27
Φαρμακευτικη συνθεση η οποια περιλαμβανει εναν μη νουκλεοσιδικο αναστολεα αναστροφης μεταγραφασης
DK2402317T3
(da )
2013-10-07
DGAT-inhibitor
BRPI0920521A2
(pt )
2018-01-16
combinação farmacêutica
BRPI1013639A2
(pt )
2016-04-19
medicamentos antidiabéticos
IT1395925B1
(it )
2012-11-02
Poliestere biodegradabile.
FR2936709B1
(fr )
2012-05-11
Comprimes alcoolo-resistants.
BRPI1016117A8
(pt )
2018-01-02
derivados de isoxazol-isoxazol e isoxazol-isotiazol.
BRPI1006505A2
(pt )
2018-05-29
embalagem
BRPI1016190A2
(pt )
2017-03-28
compostos farmacêuticos.
NL301214I2
(nl )
2023-04-19
Lasmiditan en farmaceutisch aanvaardbare zouten daarvan
BRPI0925077A2
(pt )
2015-07-21
Conjunto dispensador.
BR112013012313A2
(pt )
2019-09-24
combinação farmacêutica de paclitaxel e um inibidor de cdk
FR2953129B1
(fr )
2013-04-26
Orthese dynamique
IT1393854B1
(it )
2012-05-11
Dispenser.
IT1396487B1
(it )
2012-12-14
Convogliatore.
DK2442870T3
(da )
2014-06-30
Pyrazinooxazepin-derivater.
DK2437736T3
(da )
2017-11-13
Lægemiddelindgivelsessystemer
IT1395956B1
(it )
2012-11-02
Dispenser.
DK2403764T3
(da )
2014-06-23
Opbevaringsæske
BRPI0924400A2
(pt )
2017-05-30
artigo absorvente.
AP2011006033A0
(en )
2011-12-31
Simalikalactone E and use thereof as a medicament.
ES1073526Y
(es )
2011-03-24
Almohada.